BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31128988)

  • 1. [Skull base meningioma: Clinical and radiological efficacy based on a quantitative volumetric analysis].
    Brahimi Y; Antoni D; Srour R; Wagner P; Proust F; Thiery A; Labani A; Noël G
    Cancer Radiother; 2019 Jul; 23(4):290-295. PubMed ID: 31128988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Base of the skull meningioma: Efficacy, clinical tolerance and radiological evaluation after radiotherapy].
    Brahimi Y; Antoni D; Srour R; Proust F; Cebula H; Labani A; Noël G
    Cancer Radiother; 2018 May; 22(3):264-286. PubMed ID: 29773473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic Radiosurgery of Central Skull Base Meningiomas-Volumetric Evaluation and Long-Term Outcomes.
    Patibandla MR; Lee CC; Sheehan J
    World Neurosurg; 2017 Dec; 108():176-184. PubMed ID: 28882711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meningioma of the skull base: long-term outcome after image-guided stereotactic radiotherapy.
    Kaul D; Budach V; Misch M; Wiener E; Exner S; Badakhshi H
    Cancer Radiother; 2014 Dec; 18(8):730-5. PubMed ID: 25307475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcome after high-precision radiotherapy for skull base meningiomas: Pooled data from three large German centers for radiation oncology.
    Combs SE; Farzin M; Boehmer J; Oehlke O; Molls M; Debus J; Grosu AL
    Radiother Oncol; 2018 May; 127(2):274-279. PubMed ID: 29598834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cranial nerve outcomes after primary stereotactic radiosurgery for symptomatic skull base meningiomas.
    Faramand A; Kano H; Niranjan A; Johnson SA; Hassib M; Park KJ; Arai Y; Flickinger JC; Lunsford LD
    J Neurooncol; 2018 Sep; 139(2):341-348. PubMed ID: 29691775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic contrast-enhanced magnetic resonance imaging perfusion characteristics in meningiomas treated with resection and adjuvant radiosurgery.
    Chidambaram S; Pannullo SC; Roytman M; Pisapia DJ; Liechty B; Magge RS; Ramakrishna R; Stieg PE; Schwartz TH; Ivanidze J
    Neurosurg Focus; 2019 Jun; 46(6):E10. PubMed ID: 31153141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normofractionated stereotactic radiotherapy versus CyberKnife-based hypofractionation in skull base meningioma: a German and Italian pooled cohort analysis.
    Alfredo C; Carolin S; Güliz A; Anne K; Antonio P; Alberto C; Stefano P; Antonino G; Harun B; Markus K; Franziska M; Phuong N; Franziska L; Peter V; Volker B; David K
    Radiat Oncol; 2019 Nov; 14(1):201. PubMed ID: 31718650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skull base meningiomas: Long-term results and patient self-reported outcome in 507 patients treated with fractionated stereotactic radiotherapy (FSRT) or intensity modulated radiotherapy (IMRT).
    Combs SE; Adeberg S; Dittmar JO; Welzel T; Rieken S; Habermehl D; Huber PE; Debus J
    Radiother Oncol; 2013 Feb; 106(2):186-91. PubMed ID: 22906549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High precision focused irradiation in the form of fractionated stereotactic conformal radiotherapy (SCRT) for benign meningiomas predominantly in the skull base location.
    Jalali R; Loughrey C; Baumert B; Perks J; Warrington AP; Traish D; Ashley S; Brada M
    Clin Oncol (R Coll Radiol); 2002 Apr; 14(2):103-9. PubMed ID: 12069116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes of fractionated stereotactic radiotherapy for intracranial skull base benign meningiomas in single institution.
    Onodera S; Aoyama H; Katoh N; Taguchi H; Yasuda K; Yoshida D; Surtherland K; Suzuki R; Ishikawa M; Gerard B; Terasaka S; Shirato H
    Jpn J Clin Oncol; 2011 Apr; 41(4):462-8. PubMed ID: 21177777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome after particle therapy for meningiomas of the skull base: toxicity and local control in patients treated with active rasterscanning.
    El Shafie RA; Czech M; Kessel KA; Habermehl D; Weber D; Rieken S; Bougatf N; Jäkel O; Debus J; Combs SE
    Radiat Oncol; 2018 Mar; 13(1):54. PubMed ID: 29587795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High efficacy of fractionated stereotactic radiotherapy of large base-of-skull meningiomas: long-term results.
    Debus J; Wuendrich M; Pirzkall A; Hoess A; Schlegel W; Zuna I; Engenhart-Cabillic R; Wannenmacher M
    J Clin Oncol; 2001 Aug; 19(15):3547-53. PubMed ID: 11481362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggressive surgery and focal radiation in the management of meningiomas of the skull base: preservation of function with maintenance of local control.
    Black PM; Villavicencio AT; Rhouddou C; Loeffler JS
    Acta Neurochir (Wien); 2001; 143(6):555-62. PubMed ID: 11534672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensity-modulated stereotactic radiotherapy vs. stereotactic conformal radiotherapy for the treatment of meningioma located predominantly in the skull base.
    Baumert BG; Norton IA; Davis JB
    Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):580-92. PubMed ID: 12957272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypofractionated stereotactic radiation therapy in skull base meningiomas.
    Navarria P; Pessina F; Cozzi L; Clerici E; Villa E; Ascolese AM; De Rose F; Comito T; Franzese C; D'Agostino G; Lobefalo F; Fogliata A; Reggiori G; Fornari M; Tomatis S; Bello L; Scorsetti M
    J Neurooncol; 2015 Sep; 124(2):283-9. PubMed ID: 26040487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skull base meningioma - comparison of intensity-modulated radiotherapy planning techniques using the moduleaf micro-multileaf collimator and helical tomotherapy.
    Estall V; Fairfoul J; Jena R; Jefferies SJ; Burton KE; Burnet NG
    Clin Oncol (R Coll Radiol); 2010 Apr; 22(3):179-84. PubMed ID: 20171061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short diameter may be a useful simple indicator of the tumor response in skull base meningiomas after conventionally fractionated stereotactic radiotherapy.
    Takehana K; Nakamura D; Abdelghaffar A; Uto M; Katagiri T; Arakawa Y; Mineharu Y; Miyamoto S; Mizowaki T
    Eur Radiol; 2021 Aug; 31(8):6367-6373. PubMed ID: 33569622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volumetric response of intracranial meningioma after photon or particle irradiation.
    Mozes P; Dittmar JO; Habermehl D; Tonndorf-Martini E; Hideghety K; Dittmar A; Debus J; Combs SE
    Acta Oncol; 2017 Mar; 56(3):431-437. PubMed ID: 27911139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of stereotactic radiosurgery, hypofractionated, and fractionated stereotactic radiotherapy in the treatment of skull base meningioma.
    Han J; Girvigian MR; Chen JC; Miller MJ; Lodin K; Rahimian J; Arellano A; Cahan BL; Kaptein JS
    Am J Clin Oncol; 2014 Jun; 37(3):255-60. PubMed ID: 23241504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.